Back to Search
Start Over
Instability in theophylline and carbamazepine hydrate tablets: cocrystal formation due to release of lattice water.
- Source :
-
Pharmaceutical research [Pharm Res] 2013 Jul; Vol. 30 (7), pp. 1779-89. Date of Electronic Publication: 2013 Apr 09. - Publication Year :
- 2013
-
Abstract
- Purpose: To demonstrate two sequential solid-state reactions in intact tablets: dehydration of active pharmaceutical ingredient (API), and cocrystal formation between the anhydrous API and a second formulation component mediated by the released water. To evaluate the implication of this in situ phase transformation on the tablet dissolution behavior.<br />Methods: Tablets containing theophylline monohydrate (TPM) and anhydrous citric acid (CA) were stored at 40°C in sealed polyester pouches and the relative humidity in the headspace above the tablet was continuously measured. Dehydration to anhydrous theophylline (TPA) and the product appearance (TPA-CA cocrystal) were simultaneously monitored by powder X-ray diffractometry. Carbamazepine dihydrate and nicotinamide formed the second model system.<br />Results: The water of crystallization released by TPM dehydration was followed first by deliquescence of citric acid, evident from the headspace relative humidity (~ 68%; 40°C), and then the formation of TPA-CA cocrystal in intact tablets. The noncovalent synthesis resulted in a pronounced decrease in the dissolution rate of theophylline from the tablets. Similarly, the water released by dehydration of carbamazepine dihydrate caused the cocrystallization reaction between anhydrous carbamazepine and nicotinamide.<br />Conclusions: The water released by API dehydration mediated cocrystal formation in intact tablets and affected dissolution behavior.
Details
- Language :
- English
- ISSN :
- 1573-904X
- Volume :
- 30
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Pharmaceutical research
- Publication Type :
- Academic Journal
- Accession number :
- 23568521
- Full Text :
- https://doi.org/10.1007/s11095-013-1022-7